Use access key #2 to skip to page content.
$3.05 0.07 (2.35%)
9/8/2008 11:50 AM

MannKind Corp (MNKD)

CAPS Rating:
**

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

View All Commentary (MNKD)

Recs

1

Avatar Jonquille (< 20) Submitted: 6/17/07 2:44 PM : Outperform Start Price: $14.37 MNKD Score: -62.06

Insulin inhaler has huge market potential. Much better product than Exubera.

Report this Post Replies: 0 | Reply

Featured Broker Partners